Abstract
Introduction: Bilateral vestibular schwannomas are the hallmark of Neurofibromatosis Type 2 (NF2) and represent a major therapeutic challenge, particularly in young patients with large bilateral tumors. Management must balance long-term tumor control with preservation of facial nerve function, neurological integrity, and hearing for as long as possible. In the presence of bilateral giant lesions, treatment sequencing becomes especially important because simultaneous or overly aggressive intervention may result in profound functional impairment. Careful staging, prioritizing the lesion associated with the greatest mass effect or risk of neurological deterioration, is therefore essential. Case Report: A 24-year-old man with a strong family history of NF2 underwent screening MRI despite being neurologically asymptomatic. Imaging revealed bilateral giant vestibular schwannomas occupying the cerebellopontine angles and producing significant brainstem compression, with the larger lesion located on the left side. Given the substantial tumor burden and the risk of progressive brainstem compression, a staged surgical strategy was planned, beginning with treatment of the larger and more threatening lesion while preserving function on the contralateral side. Gross-total resection of the left vestibular schwannoma was performed through a retrosigmoid approach with the patient in the park-bench position. Microsurgical dissection was assisted by ultrasonic aspiration and continuous intraoperative neurophysiological monitoring, including facial motor evoked potentials. Progressive internal tumor debulking reduced mass effect and facilitated extracapsular dissection from the brainstem and adjacent neurovascular structures. Particular attention was directed toward identification and preservation of the facial nerve throughout the procedure. Complete tumor removal was achieved with anatomical and functional preservation of the facial nerve. Because of the tumor dimensions and intimate relationship with the cochlear nerve, hearing on the operated side was lost postoperatively. Nevertheless, the patient recovered without additional neurological deficits and maintained normal facial nerve function, corresponding to House-Brackmann grade I.The contralateral vestibular schwannoma was subsequently managed conservatively with serial clinical and radiological surveillance, aiming to preserve the patient’s remaining serviceable hearing for as long as safely possible. Results: Five years after surgery, the patient remains neurologically intact, with preserved serviceable hearing on the contralateral side and no clinical or radiological indication for additional intervention. Conclusion: In patients with NF2 and bilateral giant vestibular schwannomas, staged microsurgical management focused initially on the larger, brainstem-compressing lesion represents a rational and effective strategy. Modern microsurgical techniques, ultrasonic aspiration, and continuous facial nerve monitoring may allow safe gross-total resection with excellent facial nerve preservation. Careful surveillance of the contralateral tumor can prolong functional hearing and avoid premature bilateral auditory loss, emphasizing the importance of individualized long-term treatment planning in NF2.